BIO-key International, Inc. (BKYI) Q4 2023 Earnings Call Transcript
https://seekingalpha.com/article/4681817-bio-key-international-inc-bkyi-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Apr 02, 2024 - BIO-key International, Inc. (NASDAQ:NASDAQ:BKYI) Q4 2023 Earnings Conference Call April 2, 2024 10:00 AM ETCompany ParticipantsBill Jones - IRMike...
0
Palisade Bio announces 1-for-15 reverse stock split
https://seekingalpha.com/news/4087067-palisade-bio-announces-1-for-15-reverse-stock-split?source=feed_sector_healthcare
Apr 03, 2024 - Palisade Bio announces 1-for-15 reverse stock split, effective April 5, to increase share price and comply with Nasdaq listing requirements.
0
Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering
https://seekingalpha.com/article/4682514-gritstone-bio-granite-cancer-vaccine-data-overshadowed-by-offering?source=feed_all_articles
Apr 06, 2024 - Gritstone bio's GRANITE program shows promise in treating metastatic microsatellite stable colorectal cancer. Read why GRTS stock is a Buy.
0
Jefferies cuts Instil Bio to hold, cites drug discontinuation
https://seekingalpha.com/news/4089263-jefferies-cuts-instill-bio-to-hold-cites-drug-discontinuation?source=feed_sector_healthcare
Apr 12, 2024 - Jefferies downgraded Instil Bio (TIL) to hold, citing discontinuation of clinical development for the company’s drug candidate ITIL-306.
0
Is Bluebird Bio Stock a Buy?
https://www.fool.com/investing/2024/04/15/is-bluebird-bio-stock-a-buy/?source=iedfolrf0000001
Apr 15, 2024 - This small biotech is struggling to fly -- and investors should probably steer clear.
0
Mustang Bio stock tumbles 27% amid news of mass layoffs
https://seekingalpha.com/news/4089763-mustang-bio-stock-tumbles-amid-news-of-mass-layoffs?source=feed_sector_healthcare
Apr 15, 2024 - Mustang Bio (MBIO) stock tumbled 27% Monday in the wake of news that the company plans to cut around 81% of its workforce to conserve cash. Read more here.
0
Telesis Bio announces leadership transition amid new commercial focus
https://seekingalpha.com/news/4091115-telesis-bio-stock-slips-amid-new-ceo?source=feed_sector_healthcare
Apr 18, 2024 - Telesis Bio (TBIO) stock slipped as the company promoted its Chief Operating Officer Eric Esser to the CEO role. Read more here.
0
Zura Bio stock jumps on plans to raise $112.5M in private financing
https://seekingalpha.com/news/4091083-zura-bio-stock-jumps-on-plans-to-raise-1125m-in-private-financing?source=feed_sector_healthcare
Apr 18, 2024 - Zura Bio (ZURA) shares jumped around 12% after the immunology company entered into subscription agreements for a private placement.
0
Annovis Bio tumbles 53% on data for Alzheimer's candidate buntanetap
https://seekingalpha.com/news/4095540-annovis-bio-alzheimers-tumbles-53-data-alzheimers-candidate-buntanetap?source=feed_sector_healthcare
Apr 29, 2024 - Annovis Bio's Alzheimers disease candidate, buntanetap, triggers trading halts as shares fall ~53%, indicating potential disappointment in trial results. Read more here
0
Annovis Bio: Alzheimer's Phase 2/3 Topline Readout Puts Future For Buntanetap Into Question
https://seekingalpha.com/article/4688345-annovis-bio-alzheimer-phase-2-3-topline-readout-puts-buntanetap-future-into-question?source=feed_all_articles
May 01, 2024 - Annovis faces financial challenges and may see a significant decline in stock prices. Find out why ANVS stock is a Sell.
0